Skip to content

A Post Market Clinical Follow-up Study With the aneXys Cup

A Post Market Clinical Follow-up Study With the aneXys Cup

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03274830
Enrollment
102
Registered
2017-09-07
Start date
2020-03-05
Completion date
2032-03-01
Last updated
2026-02-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Arthroplasty, Replacement, Hip

Keywords

primary osteoarthritis, secondary osteoarthritis, femoral head fracture, necrosis

Brief summary

The purpose of the study is the evaluation of the clinical and radiological short- to long-term safety and performance of the aneXys cup. The data will be used for an ongoing evaluation of the product safety and performance.

Detailed description

Prospective observational multicenter case series providing short-term migration results and long-term post-market clinical data on the safety and performance of the aneXys cup. The study includes patients undergoing primary total hip arthroplasty. In total 100 patients in 3 clinics will be included. In each clinic 10-57 consecutive patients shall be included. In addition, to meet the regulatory requirements, a total of minimum 20 cases with screw fixation shall be included in the study. Clinical and radiological follow-up (FU) is planned after 6-12 weeks, 6 months, 1, 2, 5, 7 and 10 years. An additional FU at 3 years is planned to apply for an ODEP (Orthopaedic Data Evaluation Panel) rating.

Interventions

DEVICEaneXys

150 patients with the aneXys cup

Sponsors

Mathys Ltd Bettlach
Lead SponsorINDUSTRY

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* Informed consent form (signed by participant and investigator) * Primary implantation * Suffer from primary or secondary osteoarthritis of the hip, femoral head and neck fractures or necrosis of the femoral head. In all cases a stable anchoring of the implant has to be possible. * Age at inclusion: between 18 and 75 years old * Willing to participate in the follow-up examinations * Complete recovery is expected

Exclusion criteria

* Missing informed consent form (signed by participant and investigator) * Known or suspected non-compliance (e.g. drug or alcohol abuse) * Enrolment of the investigator, his/her family, employees and other dependent persons * Patients younger 18 years old * Revision surgery * Presence of sepsis or malignant tumours * ASA (American Society of Anesthesiologists) Classification \>3 * Pregnancy

Design outcomes

Primary

MeasureTime frameDescription
Cup migration after 2 years2 yearsThe primary endpoint will be the radiographic evaluation of the acetabular cup migration based on performed EBRA measurements 2 years after surgery.

Secondary

MeasureTime frameDescription
Harris Hip Score10 yearsThe secondary endpoint will be the determination of the clinical outcome using the Harris Hip Score.
Visual analogue scale vor pain10 yearsThe secondary endpoint will be the determination of the clinical outcome using the Visual analogue scale for pain.
Visual analogue scale for satisfaction10 yearsThe secondary endpoint will be the determination of the clinical outcome using the Visual analogue scale for satisfaction.
The Western Ontario and McMaster Universities Osteoarthritis Index10 yearsThe secondary endpoint will be the determination of the clinical outcome using the WOMAC.

Countries

Germany

Contacts

PRINCIPAL_INVESTIGATORAndreas Roth, Prof.

Universitätsklinik Leipzig

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 7, 2026